Skip to main content
Tags: blink 182 | mark hoppus | cancer

Blink 182's Mark Hoppus to Take Test to Determine Whether He 'Lives or Dies'

Blink 182's Mark Hoppus to Take Test to Determine Whether He 'Lives or Dies'
Mark Hoppus of blink-182 performs onstage at the 2020 iHeartRadio ALTer EGO at The Forum on January 18, 2020 in Inglewood, California. (Photo by Rich Fury/Getty for iHeartMedia)

By    |   Monday, 12 July 2021 11:25 AM EDT

Blink 182's Mark Hoppus, who recently revealed his cancer diagnosis, will be undergoing crucial testing this week.

In a health update posted on Twitter, the vocalist and bassist tried to sound upbeat while revealing the news to fans. 

"Apologies if I’m oversharing but it’s so surreal to think that this week I’ll take a test that may very well determine if I live or die," he tweeted.  "Thanks to everyone for the positive thoughts and encouragement. I read all your replies and it means the world to me. Thank you."

In a follow-up tweet, Hoppus insisted he was "going to beat this through chemotherapy or through bone marrow transplants," adding that he was "determined to kick cancer’s a-- directly in the nuts. Love to you all. Let’s. Heckin. Go".

Hoppus revealed in June that he was battling cancer and had been undergoing chemotherapy for three months.

"It sucks and I’m scared, and at the same time I’m blessed with incredible doctors and family and friends to get me through this," he wrote in a tweet. "I still have months of treatment ahead of me but I’m trying to remain hopeful and positive. Can’t wait to be cancer free and see you all at a concert in the near future."

Days later he opened up about how he was feeling while undergoing treatment during a game of bingo on Twitch.

"I feel much better than yesterday," he told fans, according to Absolute Radio. "Yesterday was hellish for me and I woke up today feeling better - I went for a walk, and I had a decent breakfast, and I haven’t felt like I was going to throw up today, so we’ll take it as a win."

Hoppus admitted that previous rounds of chemotherapy had left him feeling "like a poisoned electrified zombie leaning up against an electric fence," but the latest round did not impact him as negatively. 

"This round of chemo I wasn’t totally stuck on the couch, miserable. I’ve actually watched movies and walked around and cleaned the house and hung out with my dogs," he said. 

Tom DeLonge, the lead vocalist and guitarist of Blink 182, revealed that he had been aware of Hoppus' diagnosis in a tweet that offered a message of support to his bandmate.  

"I too, have been aware of @markhoppus ’s cancer diagnosis for awhile now. And to add to his own words that he used today, I would also like to say that he is strong, and a super-human who is pushing through this difficult obstacle with a wide-open heart. #WeHaveHisBack," he wrote.

Related Stories:

Zoe Papadakis

Zoe Papadakis is a Newsmax writer based in South Africa with two decades of experience specializing in media and entertainment. She has been in the news industry as a reporter, writer and editor for newspapers, magazine and websites.

© 2025 Newsmax. All rights reserved.


TheWire
Blink 182's Mark Hoppus, who recently revealed his cancer diagnosis, will be undergoing crucial testing this week.
blink 182, mark hoppus, cancer
459
2021-25-12
Monday, 12 July 2021 11:25 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved